Fabrication of Mechanically Reinforced Gelatin/Hydroxyapatite Bio-Composite Scaffolds by Core/Shell Nozzle Printing for Bone Tissue Engineering.
Biocompatible Materials
/ chemistry
Bone and Bones
/ cytology
Calcium Phosphates
/ chemistry
Cell Differentiation
/ drug effects
Cell Line, Tumor
Cell Proliferation
/ drug effects
Durapatite
/ chemistry
Gelatin
/ chemistry
Humans
Osteoblasts
/ cytology
Osteogenesis
/ drug effects
Polyesters
/ chemistry
Porosity
Printing, Three-Dimensional
Tissue Engineering
/ methods
Tissue Scaffolds
/ chemistry
bioceramic
core-shell printing
hard tissue engineering
hydroxyapatite (HA)
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 May 2020
11 May 2020
Historique:
received:
28
04
2020
revised:
07
05
2020
accepted:
07
05
2020
entrez:
15
5
2020
pubmed:
15
5
2020
medline:
23
2
2021
Statut:
epublish
Résumé
In tissue engineering, biocompatible scaffolds are used as 3D cell niches to provide a similar environment to that of native tissue for seeded cells to regenerate the target tissue. When engineering bone tissue, high mechanical strength and calcium phosphate composition are essential factors to consider. In this study, we fabricated biocompatible composite scaffolds composed of synthetic polymers (polycaprolactone (PCL) and poly (vinyl alcohol) (PVA)), natural polymers (gelatin and collagen) and bioceramic (hydroxyapatite; HA) for bone tissue engineering. The synthetic polymers were used to enhance the mechanical properties of the composite scaffolds while the natural protein-based polymers were used to enhance various cellular activities, such as cell adhesion and proliferation. Meanwhile, the bioceramic was introduced to promote osteogenic differentiation. Composite scaffolds were evaluated for their physical characteristics, such as mechanical, swelling and protein absorbing properties as well as biological properties (cell proliferation, alkaline phosphatase (ALP) activities and calcium deposition) with human osteoblast-like cells (MG63). Consequently, incorporation of hydroxyapatite into the gelatin/PVA (C-GPH) scaffold showed 5-fold and 1.5-fold increase in calcium deposition and ALP activities, respectively compared to gelatin/PVA scaffold (C-GP). Moreover, compressive modulus also increased 1.8-fold. Integration of PCL core into gelatin/PVA/hydroxyapatite scaffold (C-PGPH) further amplified the compressive modulus 1.5-fold. In conclusion, the scaffold that is reinforced with HA particles and integrated with PCL core of the struts showed significant potential in field of bone tissue engineering.
Identifiants
pubmed: 32403422
pii: ijms21093401
doi: 10.3390/ijms21093401
pmc: PMC7247670
pii:
doi:
Substances chimiques
Biocompatible Materials
0
Calcium Phosphates
0
Polyesters
0
polycaprolactone
24980-41-4
Gelatin
9000-70-8
Durapatite
91D9GV0Z28
calcium phosphate
97Z1WI3NDX
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Research Foundation of Korea
ID : NRF-2018R1A2B2005263
Références
Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:701-714
pubmed: 28482581
J Biomater Sci Polym Ed. 2018 May - Jun;29(7-9):863-893
pubmed: 29053081
Biomed Mater. 2008 Jun;3(2):022001
pubmed: 18523339
Cell Cycle. 2016;15(2):196-212
pubmed: 26825227
Int J Biol Macromol. 2016 Dec;93(Pt B):1390-1401
pubmed: 27316767
Injury. 2011 Sep;42 Suppl 2:S26-9
pubmed: 21714968
Biomaterials. 2001 Jan;22(1):87-96
pubmed: 11085388
Biofabrication. 2017 Nov 14;9(4):044103
pubmed: 28990579
Int J Nanomedicine. 2014 Aug 06;9:3687-706
pubmed: 25125978
Int J Biol Macromol. 2019 Aug 15;135:21-28
pubmed: 31100404
Colloids Surf B Biointerfaces. 2013 Nov 1;111:107-16
pubmed: 23792546
Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:325-335
pubmed: 30678918
Int J Biol Macromol. 2018 Dec;120(Pt A):119-127
pubmed: 30056041
Biomater Sci. 2017 Aug 22;5(9):1690-1698
pubmed: 28686244
Biomaterials. 2006 Jun;27(18):3413-31
pubmed: 16504284
Tissue Eng. 2007 May;13(5):927-38
pubmed: 17430090
Biomaterials. 2006 Mar;27(8):1399-409
pubmed: 16169074
FASEB J. 1990 Oct;4(13):3111-23
pubmed: 2210157
Crit Rev Oral Biol Med. 1992;3(3):269-305
pubmed: 1571474